Valuation: Olympus Corporation

Market Cap 1,932B 12.27B 10.67B 9.94B 9.14B 17.23B 1,172B 17.54B 117B 45.91B 584B 46.16B 45.15B P/E 2027 *
20x
P/E 2028 * 16.7x
Enterprise Value 1,998B 12.69B 11.03B 10.28B 9.45B 17.82B 1,212B 18.14B 120B 47.47B 604B 47.73B 46.68B EV / Sales 2027 *
1.87x
EV / Sales 2028 * 1.79x
Free-Float
94.53%
Yield 2027 *
1.7%
Yield 2028 * 1.77%
1 day-0.05%
1 week+5.17%
Current month-0.05%
1 month+5.88%
3 months+15.79%
6 months-2.41%
Current year-8.34%
1 week 1,761
Extreme 1761
1,887.5
1 month 1,703
Extreme 1703
1,887.5
Current year 1,302.5
Extreme 1302.5
2,137
1 year 1,302.5
Extreme 1302.5
2,168
3 years 1,302.5
Extreme 1302.5
2,867
5 years 1,302.5
Extreme 1302.5
3,198
10 years 758.75
Extreme 758.75
3,198
Manager TitleAgeSince
Chief Executive Officer 63 2025-05-31
Director of Finance/CFO 59 2026-03-31
Chief Tech/Sci/R&D Officer - -
Director TitleAgeSince
Chairman 69 2023-03-31
Director/Board Member 41 2019-05-31
Director/Board Member 63 2019-05-31
Change 5-day change 1-year change 3-year change Capi.($)
-0.05%+5.17%-0.30%-20.06% 12.13B
-0.05%+1.02%+23.97%+3.66% 212B
+1.29%+3.13%+0.21%-23.41% 137B
+6.25%+11.23%-22.29%+19.61% 125B
+3.64%+9.45%-54.06%-4.33% 69.46B
+3.20%+7.49%+11.96%+10.50% 49.56B
+6.10%+11.55%-15.77%-20.80% 47.2B
+1.03%+0.89%+23.17%+9.47% 39.08B
-0.68%+0.02%+29.08%+28.44% 37.05B
-3.38%+2.10%+109.34%+4.54% 30.97B
Average +0.92%+3.39%+10.53%+0.76% 75.97B
Weighted average by Cap. +1.10%+2.84%+5.00%+0.76%

Financials

2027 *2028 *
Net sales 1,068B 6.78B 5.9B 5.49B 5.05B 9.53B 648B 9.7B 64.4B 25.37B 323B 25.51B 24.95B 1,108B 7.04B 6.12B 5.7B 5.24B 9.88B 672B 10.06B 66.82B 26.33B 335B 26.47B 25.89B
Net income 98.69B 627M 545M 508M 467M 880M 59.85B 896M 5.95B 2.34B 29.84B 2.36B 2.31B 117B 744M 647M 603M 554M 1.05B 71.05B 1.06B 7.07B 2.78B 35.43B 2.8B 2.74B
Net Debt 65.76B 418M 363M 338M 311M 587M 39.88B 597M 3.97B 1.56B 19.89B 1.57B 1.54B 56.53B 359M 312M 291M 268M 504M 34.28B 513M 3.41B 1.34B 17.1B 1.35B 1.32B
Logo Olympus Corporation
Olympus Corp is a Japan-based company mainly engaged in the manufacture and sale of endoscopes, therapeutic equipment, scientific and other products. The Company operates through three business segments. The Endoscope segment provides gastrointestinal endoscopes, surgical endoscopes, and medical services. The Therapeutic Equipment segment provides gastrointestinal treatment instruments, urology products, respiratory products, energy devices, otolaryngology products and gynecology products. The Others segment provides biomaterials and orthopedic instruments. The Company is also engaged in the business activities, including holding companies and financial investments related to each business.
Employees
28,138
Date Price Change Volume
26-08-03 ¥1,819.00 -0.05% 4,210,500
26-07-31 ¥1,820.00 -2.02% 5,361,000
26-07-30 ¥1,857.50 -0.27% 3,701,100
26-07-29 ¥1,862.50 +3.36% 5,946,400
26-07-28 ¥1,802.00 -0.63% 3,909,500
Trader
Investor
Global
Quality
ESG MSCI
BB
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
14
Last Close Price
1,819.00JPY
Average target price
1,916.92JPY
Spread / Average Target
+5.38%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. 7733 Stock